Standout Papers

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung C... 2008 2026 2014 2020 677
  1. Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups (2008)
    Gary M. Strauss, James E. Herndon et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 80 standout
Sub-graph 1 of 18

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
19 intermediate papers

Works of Dorothy Watson being referenced

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
2008 Standout
Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633
2006
and 2 more

Author Peers

Author Last Decade Papers Cites
Dorothy Watson 1719 2279 367 31 3.1k
Panos Fidias 1673 1811 914 58 2.9k
Hari M. Dhingra 1269 1698 251 31 2.2k
J. Mezger 1870 1655 733 53 3.3k
Walter L. Eaton 1527 1947 260 23 2.7k
RJ Stephens 1190 1581 182 43 2.4k
Matteo Giaj Levra 1835 2223 584 67 3.0k
Russell F. DeVore 2708 2350 1256 27 3.8k
Pierre Ruffiè 1667 3570 475 85 4.8k
V. Bonfante 1651 934 332 58 3.4k
Robert T. Eagan 1091 1521 268 71 2.2k

All Works

Loading papers...

Rankless by CCL
2026